March 2023 in “Медицинский совет” In this study, 77% of androgenetic alopecia patients showed hair regrowth with minoxidil treatment, while lower SULT1A1 enzyme activity, ATP concentration, and initial hair density were identified as negative prognostic factors for treatment response.
This article reviews various aspects of hair and hair loss but does not report new research findings.
30 citations
,
May 2018 in “Experimental Dermatology” This article reviews the cellular dynamics affecting dermal papilla size in androgenetic alopecia and suggests targeting DP size could improve therapies, but it presents no new clinical data.
This article discusses the nature and causes of hair loss, including hereditary factors, but reports no new clinical findings.
2 citations
,
February 2009 in “Journal of Evidence-Based Medicine” This review of randomized controlled trials for alopecia areata treatments found that none were significantly better than placebo in promoting long-term hair growth, with most trials being small and poorly reported.
1 citations
,
September 2002 in “PubMed” This study found that using a topical 2% minoxidil solution for 6-12 months may reduce hair loss and improve hair root conditions in some women with androgenic alopecia.
14 citations
,
April 1987 in “PubMed” In an open trial, 2.8% minoxidil solution applied topically stimulated new hair growth in 45% of male patients with male pattern alopecia, though patient self-assessments were more favorable than objective evaluations.
24 citations
,
February 1987 in “Drugs” Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.
80 citations
,
October 1983 in “BMJ” This study found that 1% topical minoxidil induced significant hair regrowth in patients with alopecia areata, though it was less effective for those with extensive hair loss such as alopecia totalis and universalis.
